Glenmark Pharmaceuticals has informed that it has attached a media release on 23rd June 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials’ which is self?explanatory.
The above information is a part of company’s filings submitted to BSE.